Orthofix International Schedules Fourth Quarter 2014 Earnings Release and Conference Call for April 29, 2015

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V., (NASDAQ: OFIX) (the “Company”), a diversified, global medical device company, announced today that it plans to release fourth quarter 2014 financial results after market close on Wednesday, April 29, 2015. Brad Mason, Chief Executive Officer and Doug Rice, Interim Chief Financial Officer will host a conference call and webcast to review the Company’s results at 4:30 p.m. EDT the same day.

Interested parties may access the conference call by dialing (888) 267-2845 in the U.S. and (973) 413-6102 outside the U.S., and entering the conference ID 38220. A replay of the call will be available for two weeks by dialing (800) 332-6854 in the U.S. and (973) 528-0005 outside the U.S., and entering the conference ID 38220. A webcast of the conference call may be accessed by going to the Company’s website at www.orthofix.com, by clicking on the Investors link and then the Events and Presentations page.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on improving patients’ lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, Texas, the Company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the Company’s sales representatives, distributors and its subsidiaries. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation and the Texas Scottish Rite Hospital for Children. For more information, please visit www.orthofix.com.

Orthofix International N.V.
Investor Contact:
Mark Quick, 214-937-2924
[email protected]
or
Media Contact:
Denise Landry, 214-937-2529
[email protected]

Source: Orthofix International N.V.

You May Also Be Interested In

• Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
• European stocks mixed; Euro banking sector, Meta Platforms in the spotlight
• Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance